Department Of Biomedical Informatics

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response. Read More

Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder. Read More

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read More

Chris Lehmann, M.D., professor of Pediatrics and Biomedical Informatics at Vanderbilt, has been appointed by the U.S. Government Accountability Office as the first pediatrician to serve on the Health Information Technology (HIT) Policy Committee. Read More

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response. Read More

The pulmonary arterial hypertension knowledgebase (PAHKB), developed by Vanderbilt researchers, provides a useful tool for identifying PAH-related genes and signaling pathways relevant to pathogenesis. Read More

Russ Altman, M.D., Ph.D., professor of Bioengineering, Genetics and Medicine at Stanford University, posed an intriguing question at last week’s Discovery Lecture: is it possible to predict drug side effects from the 3D-structure of proteins? Read More

Faculty members Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, and Paul Harris, Ph.D., associate professor of Biomedical Informatics and research associate professor of Biomedical Engineering, are among six fellows elected this year to the American College of Medical Informatics. Read More

Using computational tools to search for the genetic basis of what makes us human, Vanderbilt Assistant Professor of Biomedical Informatics Tony Capra and colleagues at the University of California-San Francisco have identified promising candidate regions. Read More

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer. Read More

Tony Capra, Ph.D., is a new assistant professor of Biomedical Informatics and investigator in the Center for Human Genetics Research at Vanderbilt. His goal is to use the tools of computer science to address problems in genetics, evolution and biomedicine. Read More

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

Vanderbilt University School of Medicine has created a new office to manage the technical support necessary to make the dramatic shift in educational techniques under Curriculum 2.0. Read More

The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification. Read More

Jesse Ehrenfeld, M.D., MPH, associate professor of Anesthesiology, Surgery and Biomedical Informatics, has been named editor-in-chief of the Journal of Medical Systems, succeeding Ralph Grams, M.D., professor of Pathology and Medical Informatics at the University of Florida College of Medicine. Read More

Diagnostic codes used for billing purposes effectively identify smokers in a general clinic population and can be used to adjust smoking status in genetic and epidemiologic studies. Read More

Blackford Middleton, M.D., MPH, M.Sc., corporate director of clinical informatics research and development at Partners Healthcare in Boston, will join Vanderbilt later this month in the role of assistant vice chancellor for Health Affairs and chief informatics officer for Vanderbilt University Health System. He succeeds John Doulis, M.D. Read More

Vanderbilt’s Department of Biomedical Informatics remains exceptionally well represented on the nine-member executive committee of the American College of Medical Informatics (ACMI). Read More

Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together. Read More

MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor. Read More